Product Information
OLOPATADINE HCL 0.1% EYE DROP is a generic product labeled by SOLA Pharmaceuticals LLC, priced at $1.2228 per ML under NDC 70512052005. Its NADAC has been published 205 times since Jul 27, 2022.
Strength
1 mg/mL
Manufacturer
SOLA Pharmaceuticals LLCNDC
70512052005
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203152On Market Since
7/5/2022
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.1% EYE DROP has been published 205 times since Jul 27, 2022, and over the history we have for it it has declined 15.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2228 per ML |
|---|---|
| All-time high | $1.7041 (Oct 12, 2022) |
| All-time low | $1.0948 (Nov 20, 2024) |
| 52-week high | $1.4027 |
| 52-week low | $1.2029 |
| Median price | $1.3253 |
| Average price | $1.3543 |
| Largest weekly change | -18.3% (Oct 19, 2022) |
| Weeks tracked | 205 |
| Tracking since | Jul 27, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Olopatadine Hcl market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.1% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.1% EYE DROP, manufactured by SOLA Pharmaceuticals LLC, is $1.2228 per ML (NDC 70512052005), effective Jun 24, 2026.
How has the price of OLOPATADINE HCL 0.1% EYE DROP changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.1% EYE DROP has declined 15.9%. It has been tracked across 205 weekly CMS publications since Jul 27, 2022.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.1% EYE DROP?
Since Jul 27, 2022, the NADAC for OLOPATADINE HCL 0.1% EYE DROP has ranged from a low of $1.0948 (Nov 20, 2024) to a high of $1.7041 (Oct 12, 2022), with a median of $1.3253 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.1% EYE DROP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OLOPATADINE HCL 0.1% EYE DROP, so no direct lower-cost alternative is listed.
Who manufactures OLOPATADINE HCL 0.1% EYE DROP?
OLOPATADINE HCL 0.1% EYE DROP (NDC 70512052005) is labeled by SOLA Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification